4//SEC Filing
HOLUBIAK MYRON Z 4
Accession 0001013762-23-003533
CIK 0001506251other
Filed
Oct 11, 8:00 PM ET
Accepted
Oct 12, 4:15 PM ET
Size
24.6 KB
Accession
0001013762-23-003533
Insider Transaction Report
Form 4
HOLUBIAK MYRON Z
DirectorVice Chairman
Transactions
- Award
Options to Purchase Common Stock
2023-10-10+400,000→ 400,000 totalExercise: $0.70Exp: 2033-10-10→ Common Stock (400,000 underlying)
Holdings
- 40,000
Options to Purchase Common Stock
Exercise: $3.45Exp: 2027-09-13→ Common Stock (40,000 underlying) - 784,314
Warrant to Purchase Common Stock
Exercise: $1.15Exp: 2024-08-14→ Common Stock (784,314 underlying) - 129,450
Warrant to Purchase Common Stock
Exercise: $1.42Exp: 2024-04-05→ Common Stock (129,450 underlying) - 175,000
Options to Purchase Common Stock
Exercise: $0.67Exp: 2029-10-08→ Common Stock (175,000 underlying) - 10,000(indirect: See footnote)
Options to Purchase Common Stock
Exercise: $2.00Exp: 2031-07-22→ Common Stock (10,000 underlying) - 650,000
Options to Purchase Common Stock
Exercise: $2.04Exp: 2031-10-11→ Common Stock (650,000 underlying) - 1,992,243
Common Stock
- 26,667
Options to Purchase Common Stock
Exercise: $8.10Exp: 2025-10-01→ Common Stock (26,667 underlying) - 150,000
Options to Purchase Common Stock
Exercise: $1.62Exp: 2028-09-04→ Common Stock (150,000 underlying) - 300,000
Options to Purchase Common Stock
Exercise: $2.00Exp: 2031-07-22→ Common Stock (300,000 underlying) - 558,597
Warrant to Purchase Common Stock
Exercise: $0.77Exp: 2024-09-27→ Common Stock (558,597 underlying) - 200,000
Options to Purchase Common Stock
Exercise: $1.01Exp: 2030-10-06→ Common Stock (200,000 underlying) - 15,000(indirect: See footnote)
Options to Purchase Common Stock
Exercise: $2.04Exp: 2031-10-11→ Common Stock (15,000 underlying) - 400,000
Options to Purchase Common Stock
Exercise: $1.25Exp: 2032-10-04→ Common Stock (400,000 underlying)
Footnotes (11)
- [F1]The warrant is fully vested and exercisable immediately.
- [F10]The options were granted on October 4, 2022. The options will vest 1/3 on each of the one-year, two-year and three-year anniversary of the Vesting Commencement Date, provided that the Optionee provides Continuous Service to the Company as of each such vesting date.
- [F11]The options were granted on October 10, 2023. The options will vest 1/3 on each of the one-year, two-year and three-year anniversary of the Vesting Commencement Date, provided that the Optionee provides Continuous Service to the Company as of each such vesting date.
- [F2]The options vested in full On December 31, 2016.
- [F3]The options vested in full on September 13, 2020.
- [F4]The options vested in full on September 4, 2021.
- [F5]The options vested in full on October 8, 2022.
- [F6]The options vested in full on October 6, 2023.
- [F7]The options were granted on July 22, 2021. The options will vest 1/3 on each of the one-year, two-year and three-year anniversary of the Vesting Commencement Date, provided that the Optionee provides Continuous Service to the Company as of each such vesting date.
- [F8]The options are held by the Reporting Person's daughter. The Reporting Person disclaims beneficial ownership in these shares.
- [F9]The options were granted on October 11, 2021. The options will vest 1/3 on each of the one-year, two-year and three-year anniversary of the Vesting Commencement Date, provided that the Optionee provides Continuous Service to the Company as of each such vesting date.
Documents
Issuer
Citius Pharmaceuticals, Inc.
CIK 0001506251
Entity typeother
Related Parties
1- filerCIK 0001199080
Filing Metadata
- Form type
- 4
- Filed
- Oct 11, 8:00 PM ET
- Accepted
- Oct 12, 4:15 PM ET
- Size
- 24.6 KB